RxDoctor Payments Data

Melanie McKnight, MD

Hospitalist · Baton Rouge, LANPI 1073546149

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $669 and has fallen 96.3% since, to $25 in 2025. Among hospitalist clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,741in general payments, 2019–2025

Across 60 payments — averaging $29.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$319
  • Boehringer Ingelheim$288
  • AstraZeneca$235
  • E.r. Squibb & Sons, L.L.C.$134
  • Acadia Pharmaceuticals Inc$115
  • Johnson & Johnson$100
  • plus $549 from 15 others

What the payments were for

  • Food & beverage$1,64194%
  • Education$1006%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,741 in reported general payments places this provider in the 90th percentile of 301 hospitalist providers in Louisiana.

See all hospitalist providers in Louisiana

Medicare billing

Part B allowed, 2024
$44,073
Medicare patients
155
Services billed
416

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mirtazapine14$437
Famotidine13$391
Pantoprazole Sodium38$187
Nitroglycerin15$143
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$118
Amlodipine Besylate16$112
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$105
Metoprolol Succinate23$103
Atorvastatin Calcium12$76
Levofloxacin17$59
Furosemide23$53
Prednisone19$40

Paid to pharmacies, not to this prescriber.

Other hospitalist in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →